Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project-Reference-Cited by-同舟云学术

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Published:2014-04-25 Issue:16 Volume:120 Page:2464-2471
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Carson Kenneth R.¹,Newsome Scott D.²,Kim Ellen J.³⁴,Wagner-Johnston Nina D.¹,von Geldern Gloria⁵,Moskowitz Craig H.⁶,Moskowitz Alison J.⁶,Rook Alain H.³⁴,Jalan Pankaj⁷,Loren Alison W.⁸,Landsburg Daniel⁸,Coyne Thomas⁹,Tsai Donald⁸,Raisch Dennis W.¹⁰,Norris LeAnn B.¹¹,Bookstaver P. Brandon¹¹,Sartor Oliver¹¹²,Bennett Charles L.¹¹¹³¹⁴

Affiliation:

1. Division of Medical Oncology; Washington University School of Medicine; St Louis Missouri

2. Division of Neuroimmunology and Neuroinfectious Diseases; Johns Hopkins School of Medicine; Baltimore Maryland

3. Division of Dermatology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania

4. Division of Medical Oncology; Perelman School of Medicine at the University of Pennsylvania; Philadelphia Pennsylvania

5. Department of Neurology; Johns Hopkins School of Medicine; Baltimore Maryland

6. Division of Hematologic Oncology; Memorial Sloan-Kettering Cancer Center; New York New York

7. Division of Neurology; Southern Illinois College of Medicine; Springfield Illinois

8. Abramson Cancer Center; University of Pennsylvania; Philadelphia Pennsylvania

9. Department of Pathology and Laboratory Medicine, Robert Wood Johnson School of Medicine; Rutgers University; Piscataway New Jersey

10. University of New Mexico College of Pharmacy; VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center; Albuquerque New Mexico

11. Southern Network on Adverse Reactions (SONAR) Program; South Carolina College of Pharmacy; Columbia South Carolina

12. Department of Medicine; Tulane University School of Medicine; New Orleans Louisiana

13. Arnold School of Public Health; University of South Carolina; Columbia South Carolina

14. Hollings Cancer Center; Medical University of South Carolina; Charleston South Carolina

Funder

American Cancer Society

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28712/fullpdf

Reference29 articles.

1. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy;Cinque;N Engl J Med.,1998

2. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy;Sacktor;J Neurovirol.,2002

3. Progressive multifocal leukoencephalopathy;Brooks;Neurol Clin.,1984

4. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies;Garcia-Suarez;Am J Hematol.,2005

5. Progressive multifocal leukoencephalopathy in transplant recipients;Shitrit;Transpl Int.,2005

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Virus-Specific T Cell Therapy for Polyomavirus Infections: A Comprehensive Review;International Journal of Antimicrobial Agents;2024-09

2. A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD;Leukemia & Lymphoma;2024-07-27

3. Antibody drug conjugates in the clinic;Bioengineering & Translational Medicine;2024-05-04

4. Updates on the mechanisms of toxicities associated with monoclonal antibodies targeting growth factor signaling and immune cells in cancer;Toxicological Research;2024-04-22

5. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21